Pharmacogenomics

Pharmacogenomics is the study of the gene effect on a person’s response to medication. This comparatively new field combines pharmacological medicine and genetics to develop effective, safe medications and doses that may be tailored to a person’s genetic makeup. Several medications presently accessible do not work a similar manner for everybody. Adverse drug reactions are a unit of big trouble for hospitalizations. With the data gained from the HGP, researchers are learning variations in genes have an effect on the body’s response to medications.

The field of pharmacogenomics continues to be in its infancy. Its use is presently quite restricted, however new approaches are in clinical trials. In future, pharmacogenomics can permit the tailored medication to treat health issues, as well as disorders, Alzheimer sickness, cancer, HIV/AIDS, and asthma.

  • Drug-Gene Testing
  • Clinical Pharmacogenomics
  • Precision Pharmacotherapy
  • Pharmacogenetics
  • Personalized Medicine
  • Pharmacoproteomics

Related Conference of Pharmacogenomics

November 26-27, 2019

International Conference On Genomics and Molecular Biology

Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
November 26-27, 2019

International Conference on Cell and Gene Therapy

Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
June 28-30 2020

Stroke Summit 2020

July 15-16, 2020

12th World Congress and Expo on Stem Cell Research

Prague, Czech Republic
15-11-2020

molecularbiology-cs-2020

UAE,Dubai
December 07- 08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Pharmacogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in